Jakafi (Ruxolitinib)
…hydroxyurea. Acute graft-versus-host disease: Jakafi is indicated for the treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adults and pediatric patients who are over 12 years of age. Chronic graft-versus-host…